Universitetssjukhuset i Linköping

Linköping SE-581 85

3 studies enrolling now · 7 studies all time

What they study most

Advanced Metastatic (Stage IV) Colorectal Cancer, Alpha1-Antitrypsin Deficiency, Atrial Fibrillation, Cancer, Locally Advanced or Metastatic Unresectable Urothelial Cancer, Melanoma, Metabolic Dysfunction-Associated Steatotic Liver Disease, Prevention of Stroke or Systemic Embolism

Studies at this site

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• Met Non Small Cell Cancer Registry (MOMENT) — Recruiting now
• Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein — Recruiting now
• Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Completed
• Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer — Completed